Progress in Molecular Biology and Translational Science
| 短名 | Prog. Mol. Biol. Transl. Sci. |
| Journal Impact | 4.11 |
| 期刊索引 | 中科院 3 区 |
| ISSN | 1877-1173, 1878-0814 |
| h-index | 113 |
| 国内分区 | 生物学(3区)生物学生化与分子生物学(4区) |
分子生物学和转化科学进展 (PMBTS) 对具有特殊科学重要性的主题进行了深入评论。如果今天您阅读了一篇关于自然的文章或信件，或者一篇研究文章或科学报告，报告了非常重要的发现，您可能会在未来的PMBTS 卷中找到对该研究领域的全面报道。
期刊主页| 涉及主题 | 生物医学化学遗传学生物化学内科学基因细胞生物学病理心理学计算机科学物理 |
| 出版信息 | 出版商: Elsevier B.V.，出版周期: ，期刊类型: book-series |
| 基本数据 | 创刊年份: 2008，原创研究文献占比: 0.00%，自引率:N.A.， Gold OA占比: 0.00% |
| 平均审稿周期 | 网友分享经验：偏慢,4-8周 |
| 平均录用比例 | 网友分享经验：较易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
The development and technologies of RNA therapeutics
2024-1-1
Contributors
2024-1-1
Half Title Page
2024-1-1
Index
2024-1-1
Title Page
2024-1-1
Title Page
2024-1-1
Index
2024-1-1
Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases
2024-1-1
Current approaches in CRISPR-Cas system for metabolic disorder
2024-1-1
CRISPR-Cas based genome editing for eradication of human viruses
2024-1-1
Advances in CRISPR-Cas systems for fungal infections
2024-1-1
Advances in CRISPR-Cas systems for human bacterial disease
2024-1-1
Advances in CRISPR-Cas systems for blood cancer
2024-1-1
Preface
2024-1-1
RNA therapeutics for kidney injury
2024-1-1
Recent applications of RNA therapeutic in clinics
2024-1-1
RNA therapeutics for regenerative medicine
2024-1-1
Advantages and disadvantages of RNA therapeutics
2024-1-1
RNA therapeutics for infectious diseases
2024-1-1
Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatment
2024-1-1
Epidemiology of COVID-19
2024-1-1
Index
2024-1-1
Copyright
2024-1-1
Half Title Page
2024-1-1
Future insights
2024-1-1
Protein aggregation: An overview
2024-1-1
Morphological features and types of aggregated structures
2024-1-1
Regulatory considerations and intellectual property rights of repurposed drugs
2024-1-1
Biotechnological applications of amyloid fibrils
2024-1-1
Drug repurposing for regenerative medicine and cosmetics: Scientific, technological and economic issues
2024-1-1
Current approaches in identification of a novel drug targets for drug repurposing
2024-1-1
System biology approaches for drug repurposing
2024-1-1
Therapeutic approaches in proteinopathies
2024-1-1
Osmolyte-IDP interactions during desiccation
2024-1-1
Contributors
2024-1-1
Repurposing of biologics and biopharmaceuticals
2024-1-1
Computational biology approaches for drug repurposing
2024-1-1
RNA therapeutics for neurological disease
2024-1-1
CRISPR challenges in clinical developments
2024-1-1
Recent progress in CRISPR/Cas9 system for eye disorders
2024-1-1
Current approaches in CRISPR-Cas systems for hereditary diseases
2024-1-1
Application of RNA-based therapeutics in glioma: A review
2024-1-1
Structural biology of SARS-CoV-2
2024-1-1
Copyright
2024-1-1
Contributors
2024-1-1
Title Page
2024-1-1
Drug repurposing for fungal infections
2024-1-1
Drug repurposing for rare diseases
2024-1-1
Drug repurposing for neurodegenerative diseases
2024-1-1
Preface
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远